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Objective: We review our ongoing experience with a transabdominal stent repair of complex thoracoabdominal aneurysms
(Crawford type I, II, and III) with surgical revascularization of visceral and renal arteries.
Methods: A retrospective review was conducted of prospectively collected data from 29 consecutive patients who underwent an
attempted visceral hybrid procedure between January 2002 and April 2005. Twenty-two patients were elective, four were
urgent (symptomatic), and three were emergent (true rupture). The median patient age was 74 years (range, 37 to 81 years).
The aneurysms were Crawford type I in 3, type II in 18, type III in 7, and type IV in 1. Previous aortic surgery had been
performed in 13 (45%) of 29 and included aortic valve and root replacement in 3, TAA repair in 1, type I repair in 1), type IV
repair in 3, type B dissection in 2, infrarenal aneurysm in 5, and right common iliac aneurysm in 1. Severe preoperative
comorbidity was present in 23 (80%) of 29: chronic renal impairment in 5, severe chronic obstructive pulmonary disease in 6,
myocardial disease in 11 at New York Heart Association grade II (6) and grade III (5), and Marfan’s syndrome in 6.
Twenty-six patients (90%) had a completed procedure. In two patients, myocardial instability prevented completion of the
procedure despite extensive preoperative cardiac assessment, and in one, poor flow in the true lumen of a chronic type B
dissection prevented anastomosis of the revascularization grafts. Exclusion of the full thoracoabdominal aorta was achieved in
all 26 completed procedures and extended to include the iliac arteries in four, with revascularization of coeliac in 26, superior
mesenteric artery in 26, left renal artery in 21, and right renal artery in 21).
Results: There was no paraplegia <30 days or during inpatient admission, and elective and urgent mortality was 13%
(3/23). All of the patients with ruptured thoracoabdominal aneurysms died <30 days. Major complications included
prolonged respiratory support (>5 days) in 9, inotropic support in 4, renal impairment requiring temporary support in
2 and not requiring support in 2, prolonged ileus in 2, resolved left hemispheric stroke in 1, and resection of an ischemic
left colon in 1. Median blood loss was 3.9 liters (range, 1.2 to 13 liters). The median ischemia time was 15 minutes (range,
13 to 27 minutes) for the superior mesenteric and coeliac arteries and 15 minutes for the renal arteries (range, 13 to 21
minutes). The median hospital stay was 27 days (range, 16 to 84 days). Follow-up was a median of 8 months (range, 2
to 31 months), with 92 of 94 grafts patent. Six patients were found to have a type I endoleak. In four, this was a proximal
leak, and stent extension in three reduced, but did not cure, the endoleak. One patient with a distal type I endoleak was
successfully treated by embolization. Four type II endoleaks resolved without intervention, and one was treated by
occlusion coiling of the origin of the left subclavian artery. A single late type III endoleak was found.
Conclusion: Early results of visceral hybrid stent-grafts for types I, II, and III thoracoabdominal aneurysms are
encouraging, with no paraplegia in this particularly high-risk group of patients. These results have encouraged us to
perform the new procedure, in preference to open surgery, in Crawford type I, II, and III thoracoabdominal aortic
aneurysms. (J Vasc Surg 2006;43:1081-9.)From the Regional Vascular Unita and the Department of Radiology,b St
Mary’s Hospital.
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doi:10.1016/j.jvs.2005.12.071Patients undergoing thoracoabdominal aortic aneurysm
(TAAA) repair continue to be affected by high morbidity and
mortality despite advances in patient care and surgical tech-
niques.1 Data from national databases in the United States
suggest a mortality rate approaching 20%2 for repair of all
types of TAAAs combined. Audited data in the United King-
dom Cardiac Surgical Register suggests mortality for replace-
ment of the descending thoracic aorta is as high as 34%.3
Mortality is higher in patients with Crawford extent II TAAA,
pre-existing renal disease, cardiac disease, chronic obstructive
pulmonary disease, and advanced age.1,4-8 Furthermore it is
recognized that redo surgery, particularly when reopening the
1081
JOURNAL OF VASCULAR SURGERY
June 20061082 Black et althoracic cavity, is associated with increased risk.9,10 In our
own historical experience of repair (published in 1995) of
extent I, II, and III TAAAs, the mortality for elective and
urgent repair was 31% (20/64) and increased to 37% (28/75)
with inclusion of ruptures.1 Our results have improved some-
what since that report, but we have not emulated the excellent
results of some centers.
The morbidity of TAAA repair is also significant, with
major complications, including spinal cord ischemia, as high
as 15%, significant pulmonary problems in up to 40% of
patients, and renal impairment in up to 30%.4,10-12 Despite
these daunting risks in patients with significant comorbidity,
surgery remains an option because the mortality rate of con-
servative treatment at 2 years may be 76%; half of these deaths
are due to aneurysm rupture.13
The pioneering use of endovascular stents for the treat-
ment of descending thoracic aneurysms by Dake et al14 has
shown encouraging early results for a procedure that reduces
morbidity. Additionally, we reported in 200315 the combina-
tion of endovascular exclusion with visceral revascularization
for treatment of TAAAs involving the visceral aorta, termed
the visceral hybrid procedure, which several other centers have
also reported.16-22 The key principle of this procedure is that
retrograde revascularization of the visceral and renal arteries
via an abdominal approach allows for endovascular stent-
grafts to exclude a thoracoabdominal aneurysm that extends
into the visceral aorta. This article reviews our experience with
29 such cases.
PATIENTS AND METHODS
Prospectively collected data for 29 consecutive patients
who underwent an attempted visceral hybrid procedure be-
tween January 2002 and April 2005 were retrospectively
reviewed. These patients had a mean follow-up of 8 months
(range, 2 to 31 months). The median age of this group was 74
years (range, 37 to 81 years), and 13 (45%) were women.
Eighteen (62%) of these patients had a Crawford extent II
TAAA, and the remainder were divided between Crawford
extent I (n  3), extent III (n  7), and extent IV. The
etiology of the aneurysmal disease was atherosclerotic degen-
eration in 17 (59%), Marfan’s disease in six (21%), and mycotic
in one; in the remaining five (17%), all with Crawford extent II
aneurysms, this was secondary to chronic type B dissection. In
13 (45%) of 29, previous aortic surgery had been performed
(Table I). The mean aneurysmal diameter was 7.5 cm (range,
5 to 12 cm) (Table II, online only).
Elective procedures were done in 76% (n  29) of the
patients, and urgent procedures were done in 10% (3/29)
who were symptomatic but had no radiographic evidence
of leak. The remaining three patients had true ruptures of
type II TAAAs with radiographic evidence of leak and
hemodynamic instability and underwent an emergent pro-
cedure that was performed in the same manner as for
elective and urgent cases.
Surgical procedures. All cases were performed under
general and epidural anesthesia, with the patient in a supine
position. Spinal drainage, cell salvage, transfusion, and
rapid infusers were used. Transesophageal echocardiogra-phy was used during the procedure to monitor cardiac
function. The avoidance of supraceliac clamping obviated
the need for left heart or full cardiac bypass and deep
hypothermic arrest, all of which we have used in the
past.1,23
A transperitoneal abdominal approach was used, which
allowed exposure of the abdominal aorta and the origins of
the renal arteries, the celiac axis, and the superior mesen-
teric artery (SMA). The choice of inflow site for retrograde
visceral artery bypass grafting was determined for each
patient by previous abdominal aortic surgery and the extent
of the aneurysmal disease.
In the cases where a previous infrarenal (n 6) or type
IV repair (n  3) had been performed, the bypass grafts
were anastomosed in an end-to-side fashion to the existing
graft, allowing room for stent deployment more proximally
within the previous aortic graft. In one patient, infrarenal
repair with a tube graft, and in two patients, repair of
bilateral iliac aneurysms with a bifurcated infra-renal graft
was done first, and the visceral bypass grafts were subse-
quently anastomosed end-to-side to the distal part of the
infrarenal grafts. In two patients, the visceral bypass grafts
were anastomosed end-to-side to the normal infrarenal
aorta, and in one patient, a thoraco uni-iliac stent-graft was
needed, and the revascularization grafts were therefore
anastomosed to the ipsilateral external iliac artery.
In the remaining 12 patients, aneurysmal disease ex-
tended to the aortic bifurcation, and the common iliac
arteries were used as the inflow sites for the visceral by-
passes. In these latter patients, two inverted (14 7 mm or
16  8 mm) Hemashield (Boston Scientific, Wayne, NJ)
grafts were used as the conduits. The limb to the celiac axis
was tunnelled in front of the renal vein through the loose
areolar tissue behind the pancreas, and the anastomosis was
performed to the inferior aspect of the confluence between
the hepatic and left gastric arteries. The graft to the SMA
was placed in a “lazy C” fashion24 (Fig 1).
The renal artery bypasses were subsequently performed
using an end-to-side renal anastomosis. Separate grafts to
each recipient artery were done rather than a sequential
graft technique, as graft patency remains a concern. Dopp-
ler signals were then confirmed in each recipient artery in
turn, with the origins of the host vessel were ligated to
prevent endoleaks (Fig 1). The grafts were then excluded in
the retroperitoneum by primary closure or, if that was not
possible, by use of an omental flap to prevent bowel adhe-
sion and consequent problems.
After successful visceral and renal bypass, a suitable
access site was chosen for endovascular stent deployment.
This was achieved by a femoral artery cutdown in 12
patients, or through a conduit attached to the confluence of
the retrograde grafts in seven, the common iliac artery in
three, or the abdominal aorta in four. As our experience has
evolved, we have selected a conduit in preference to a
femoral approach for deployment of stent-grafts because
tortuosity of access can be a problem. This can lead to a
dissection, and any damage to the artery feeding the revas-
cularization grafts could be disastrous.
lacem
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eral side, and the stents were deployed in a sequential fashion
to exclude the aneurysm. A variety of stent-grafts were used,
and the decision was tailored on a patient-by-patient basis.
Talent stent-grafts (Medtronic, Santa Rosa, Calif) alone were
used in 12 patients, Zenith (Cook, Bloomington, Ind) devices
in five, Excluder (W. L. Gore and Assoc, Flagstaff, Ariz) grafts
alone in six, and Talent stent-grafts combined with Excluder
grafts in three. A median of three stents (range, 1 to 9) was
deployed in each patient.
Follow-up. All grafts were followed-up by computed
tomography (CT) and duplex scans. The protocol for this was
initially and at 3, 6, and 12 months, and yearly thereafter.
RESULTS
The procedure was completed in 90% (26/29) of pa-
tients. Despite extensive preoperative cardiac assessment in
patients who were known to be high risk, myocardial
instability in two patients prevented completion of the
Table I. Demographic and follow-up data (including graf
underwent the visceral hybrid procedure
Case
Number
Crawford
Type Previous Surgery Status
Proced
aband
1 I TAA open; IRAAA Elective N
2 II L thoracotomy Elective N
3 III IRAAA Elective N
4 III AV&R  2; TAA stent;
Type IV open
Urgent N
5 II Aortobiiliac repair Elective N
6 II NA Elective N
7 I JRAAA repair Elective N
8 I NA Elective N
9 II IRAAA repair Emergent N
10 II NA Elective N
11 III NA Elective N
12 IV Type IV open Elective N
13 II AV&R Elective N
14 II NA Elective N
15 II NA Elective N
16 III NA Elective Y
17 II Elective N 4
18 III Type IV open Elective N 3
19 II NA Elective Y
20 II IRAAA Elective N
21 II NA Urgent N
22 III NA Elective N
23
II NA Elective Y NA
24 III TAA stent Elective N
25 III NA Emergent N
26 II NA Emergent N
27 II AV&R Urgent N
28 II NA Urgent N
29 II NA Elective N
TAAA, Thoracoabdominal aneurysm; AV&R, aortic valve and root rep
abdominal aortic aneurysm.procedure. Visceral bypasses were not done in these pa-tients. In a further patient, who had an aneurysm secondary
to a chronic type B dissection, the procedure was aban-
doned because of a low flow rate in the true lumen that was
considered insufficient for safe revascularization of the renal
and visceral arteries.
Two of the three patients in whom the procedure was
incomplete were discharged home. There was no other
option for repair, and they are being treated conservatively.
The third patient with a chronic type B dissection died from
aneurysm rupture 10 days after the procedure was aban-
doned. The results for the remainder of this article there-
fore refer to the 26 patients in whom the procedure was
completed.
Deployment zones of the stent-grafts. The proximal
attachment site of the stent-graft was zone 2 in four pa-
tients, and zone 3 in 14 patients. In the remaining eight
patients, the stents were deployed in zone 4 distal to the
origin of the left subclavian artery in five or in an existing
thoracic Dacron graft in three. In the four patients in whom
ency and endoleaks) for 29 consecutive patients who
No of
Grafts
Initial
Endoleak
30-day
mortality
Follow up
(months)
Grafts
patent
Late or
persistent
Endoleak
4 N N 28 4 Type III
4 N N 31 4 N
4 N N 20 4 N
4 N N 20 4 N
4 N N 19 4 N
4 N N 16 4 N
3 Type I prox N 15 3 Type I prox
2 N N 15 2 N
3 N Y 14 3 N
4 Type II N 14 4 N
3 Type II N 15 3 N
3 N N 3 3 N
4 Type I
distal
N 12 3 N
4 Type II Y 2 4 N
4 N N 12 4 N
NA NA Y 1 NA N
N Y 1 4 N
Type
I prox
Y 1 3 N
NA NA N 8 NA N
4 Type I prox N 8 4 Type I prox
3 Type I
distal
Y 2 3 NA
4 Type II Y 1 4 N
NA N 6 NA N
3 Type II N 6 3 N
3 N Y 1 2 N
4 Type I prox Y 1 4 Type I prox
4 N N 3 4 N
4 N Y 1 4 N
3 N N 1 3 N
ent; IRAAA, infrarenal abdominal aortic aneurysm; JRAAA, juxtarenalt pat
ure
onedthe stents grafts were deployed in zone 2, a carotid–carotid
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performed to create the landing zone. In 14 patients, the
left subclavian was occluded, and one subsequently had
successful coil embolization. In the remainder, occlusion of
the left subclavian was confirmed on postoperative CT
scans. The distal landing zone of the stent-grafts was the
infrarenal aorta in 22 patients and the iliac arteries in four
(Fig 2).
The full thoracic and abdominal aorta was excluded in
all 26 completed procedures. In the completed procedures,
the celiac artery in 26, SMA in 26, the left renal artery in 21,
and the right renal artery in 21 were revascularized by
retrograde bypass grafts. In 10 patients, a nonfunctioning
kidney as determined by a preoperative radio-nucleotide
excretion renogram (MAG III scan) was not revascularized.
Ischemia time was a median of 15 minutes (range, 13 to 27
minutes) for revascularization of the celiac axis and SMA
and a similar median of 15 minutes (range, 13 to 21) for the
renal arteries.
Mortality. Thirty-day mortality was 13% (3/23) for
completed urgent and elective patients, and the three pa-
tients with a ruptured TAAA who underwent the procedure
died, for 23% an overall mortality for completed proce-
dures. One patient with a ruptured TAAA died intraoper-
atively, and two survived 10 days postoperatively only to
succumb to cardiac complications. In the three elective/
Table II. Radiographic characteristics of aneurysms of 29
Patient
Length proximal
neck (cm)
Diameter prox
neck (cm)
Length o
aneurysm (
1 4 2.4 31.2
2 2 3.1 25
3 3 3 32
4 4 3.4 29.5
5 3 3.8 10
6 3 3.1 32
7 2.5 4 34
8 4 4.2 25
9 4.7 3.3 33
10 2.8 3 52
11 3.6 3 35.5
12 3.3 2.7 17
13 2 3.2 44
14 3 3 30
15 4 3 33.4
16 1.8 3.3 40
17 3 2.7 33.6
18 2.7 2.5 45
19 5 2.7 40
20 2 3 34
21 3 3 40
22 6.5 4 37
23 5 2.7 33.6
24 3 3 26
25 3 2.5 27.7
25 3 2.5 27.7
26 4 3.9 36
27 2.8 4 45
28 4.9 3.5 36
29 4.5 3.3 40urgent patients who died, one died from pulmonary embo-lus on day 29 after an initially encouraging recovery, and
one died as a result of a myocardial infarction on day 10.
The third patient died as a result of “trash” embolization
after placement of visceral revascularization grafts. The first
guidewire dislodged emboli from a heavily diseased aorta
with circumferential thrombus. The emboli resulted in
widespread microinfarction in all the visceral beds.
Morbidity. No patients developed paraplegia after
this procedure. Major complications included prolonged
respiratory support (5 days) in 9 patients, prolonged
inotropic support (4 days) in 4, renal impairment requir-
ing temporary support in 2 and not requiring support in 2,
prolonged ileus (7 days) in 2, left hemispheric emboli
with total resolution of hemiplegic symptoms in 1, and
ischemia of the left colon requiring resection in 1. In one
further patient, who had repair of an extensive extent II
TAAA secondary to a chronic type B dissection, a type A
dissection developed 10 days after the initial procedure and
required an emergent Bentall procedure. Hospital stay was
a median of 27 days (range, 18 to 64 days), with a median
intensive care unit stay of 4 days (range, 2 to 40 days).
Endoleak. Overall, 11 (42%) patients had initial en-
doleaks (Table I). Six patients had type I endoleaks. In four,
this was a proximal leak that was treated by stent extension.
This cured the endoleak in one and reduced, but did not
cure, the endoleak in three. These three patients have been
nts
Max diameter of
aneurysm (cm)
Length of distal
neck (cm)
Diameter distal
landing zone (cm)
12 6.3 0.3
9.1 3 2.4
6.5 2.5 2.8
8 3 3.5
6.2 2 2.4
5 3 2.5
7.2 2.5 3.1
6 4 3
7.7 3 2.7
8 2 2.2
7.5 2 2
7.7 2 2.6
11 2 3.5
10.2 2 2
5 3 2
9 3 2.9
5.5 3 2
7.3 2 3
7.5 3 1.8
8.5 3 2.6
5.5 0 2.2
7 3 2.5
6 2 2.1
9 2.5 1.8
10 2.6 2.4
10 2.6 2.4
6.2 3 2.7
9 3 2.3
7 4 2
7.7 2 2.5patie
f
cm)followed with regular CT surveillance at 3-month intervals.
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size of the leak, assessed by contrast leak, has decreased, and
the aneurysm sac has not increased in size. These patients
may still be at risk of aneurysm rupture.
One patient with a distal type I endoleak was success-
fully treated with embolization, and one died from pulmo-
nary complications before intervention for this endoleak.
Five patients had type II endoleaks, of which four had
resolved on CT scan at 3 months. The remaining type II
endoleak resolved after occlusion coiling of the left subcla-
vian origin, as previously discussed.
Secure ligation of the origins of the visceral and renal
arteries is essential to prevent type II endoleaks, and clips
should not be used. In one patient with a significant type II
endoleak, a clip across the SMA had been displaced. A
single late type III endoleak was found, but the patient
declined further intervention and died 12 months later with
no postmortem.
Graft patency. At a median follow up of 8 months
(range, 2 to 31 months), 92 (98%) of 94 grafts remained
patent. The SMA graft occluded in one patient; however,
the patient was asymptomatic, had good collateral supply
via the celiac artery, and, therefore, no further intervention
was performed. In a further patient, a single renal graft
occluded, but the patient’s other kidney remained well
preserved with a functioning graft, and no further interven-
tion was pursued.
Aneurysms secondary to type B dissection. In our
early experience of type B dissections, two procedures were
initially abandoned as a result of low flow in the true lumen;
the aortic flow was therefore insufficient for safe visceral/
Fig 1. Completed visceral and renal retrograde revascularization
grafts show the “lazy C” configuration of the graft to the superior
mesenteric artery.renal revascularization, although limb viability was notaffected. As previously discussed, one patient in whom
procedure was not completed died from aneurysm rupture
10 days later. One patient went on to have the procedure
completed at a later date. This involved deployment of a
Palmaz stent, which increased flow in the true lumen and
made the remainder of the procedure possible.
We have now successfully treated the remaining three
patients who had Crawford extent II aneurysms secondary
to chronic dissection by performing the procedure in two
stages at separate operations. Stage one involves stent de-
ployment in the true lumen within the thoracic aorta, thus
increasing flow in the infrarenal aortic true lumen. Stage
two involves attachment of the visceral grafts to the true
lumen in the aorta or iliac arteries and subsequent deploy-
ment of further stent-grafts.
DISCUSSION
This procedure has shown early encouraging results,
with a reduction in mortality in our hands from 31% to 13%
for type I, II, and III TAAAs, and no episodes of paraplegia
have occurred in our patients. These results are particularly
encouraging considering this patient group was at a high
risk from open surgery, with serious comorbidity in 80%,
previous aortic surgery in 45%, and a further 17% had
Marfan’s syndrome.
We have been unable to emulate the best results in the
literature when performing open repairs for a number of
reasons.1 As a result, we have had a greater reason for
seeking alternative solutions to treat patients with extensive
TAAAs (not type IV), previous aortic surgery, and serious
comorbidity.
The hybrid procedure presented an attractive alterna-
tive to open repair because potential benefits could be
gained by the avoidance of thoracotomy and supraceliac
cross-clamping. We believe the reduction in visceral isch-
emia time is important, and the liver is never ischemic. We
were concerned that the complex retrograde visceral revas-
cularization grafts may not be durable and that the number
Fig 2. Landing zones of endovascular stent-grafts and extent of
aortic exclusion for 26 completed procedures.of stent-grafts deployed increased the risk of endoleaks.
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the results are still not clear. As a result, we initially reserved
this procedure for patients in whom we did not consider
open repair to be an option and continued to perform
traditional open TAAA repair alongside the hybrid proce-
dure (Fig 3). As our experience has evolved, the results have
encouraged us to use this method of repair as the treatment
of choice.
The absence of spinal cord ischemia in this small series
of patients is somewhat surprising given the extensive na-
ture of the repair and the complex disease pattern in this
group of patients. This complication has been described in
other series involving endovascular repair of isolated tho-
racic aneurysms alone, so we expect to encounter this
problem in due course. Nevertheless, the early results are
encouraging. The etiology of this complication is multifac-
torial, with prolonged ischemia as a result of aortic cross-
clamping, intraoperative hypotension, and reperfusion in-
juries all contributing to spinal cord ischemia in open
repair.25 All these factors are minimized or excluded in the
hybrid repair, which may explain the absence of paraplegia
thus far. In our experience of open surgery we encountered
a paraplegia risk of 7%.1
The necessity to exclude the entire aneurysmal thoracic
aorta in our patient group meant that we could not con-
sider antegrade grafts. We were worried by the necessity of
an awkward retrograde repair, but we have been gratified by
the early results of 98% (92/94) graft patency rate at
median follow-up of 8 months (range, 2 to 31 months)
(Table I).
The safety and durability of retrograde bypass grafting
has remained controversial. A number of case studies exist
in which patency rates have been assessed after their use in
bypass grafting for chronic mesenteric ischemia and in the
treatment of renal artery stenosis.26,27 Patency rates, as
Fig 3. Bar chart shows number of procedures performed as open
or involving stent-grafts for thoracoabdominal aneurysms and type
I, II, and III thoracoabdominal aortic aneurysms from 1997 to
2004. The first hybrid procedure was performed in 2002. The bar
for 2005 represents a projection based on numbers performed to
Jun 1 2005. The projection is highlighted in yellow.assessed by Kaplan-Maier life-table analysis, have been re-ported at 90% to 95% at 36 months in some series, which is
encouraging. Furthermore, Kansal et al28 found no differ-
ence in patency between antegrade and retrograde grafts in
this later series.27
A case report of iliorenal bypass grafting to facilitate
endovascular infrarenal abdominal aortic aneurysm re-
pair demonstrated patent grafts at 3 years follow-up.29
Graft patency is improved by careful routing of the
grafts, particularly the limb to the SMA, which is routed
in a “lazy C” fashion to avoid kinking once the bowel is
repositioned after the procedure (Fig 1). The graft to the
celiac artery is routed retroperitoneally behind the pan-
creas. The length of all grafts, which should be assessed
under arterial pressure, is crucial to successful graft place-
ment.
We do not believe that it is acceptable to sacrifice the
celiac axis in these complex patients, where to rely solely
on the SMA for vascularization of the gut is an unneces-
sary risk. We are following these grafts with regular
visceral arterial duplex scanning in addition to CT sur-
veillance and may be able to predict the grafts at risk.
However, we do not have sufficient follow-up data at this
stage, and the graft patency should be interpreted with
caution.
The avoidance of thoracotomy relies on successful
aneurysm exclusion in the thoracic segment by stent-
grafts. We have dealt with proximal type I endoleaks by
proximal stent extension requiring carotid– carotid/sub-
clavian crossover grafting to create the necessary landing
zone. Others have also noted, as in our experience with
three patients, that proximal type I endoleaks have per-
sisted despite extension of the stent into zone 1 after
carotid– carotid crossover grafting.30 In the three pa-
tients in whom a type I endoleak has persisted, the risk of
rupture of the thoracic aneurysmal segment clearly re-
mains a concern.
Distal type I endoleaks are a more specific concern
when the hybrid repair is performed because many of the
patients have no adequate landing zone in the distal
aorta. Nevertheless, we prefer to use the lower aorta or
common iliac artery for the origin of the retrograde
grafts, because we believe that the grafts should be taken
from as large a caliber host vessel as possible to help
maintain graft patency. This usually prevents the use of a
trouser stent-graft in the distal aorta. Distal type I en-
doleaks developed in two patients in our group, and we
have successfully coiled and embolized the leak in one
(the second died from pulmonary complications before
intervention).
Type III endoleaks are a risk given the number of stent
segments deployed in these complex patients; however, the
only problem we had was in the first patient in whom a
hybrid procedure was performed. A type III endoleak may
have caused a late rupture of the aneurysm 28 months after
intervention, but we where unable to confirm this because
the patient did not have a postmortem.
The long-term durability of thoracic endografts re-
mains uncertain, and these patients will need to be closely
JOURNAL OF VASCULAR SURGERY
Volume 43, Number 6 Black et al 1087followed. In a recent review of 1518 patients with thoracic
stent-grafts, primary endoleaks had developed in 118 pa-
tients. In only 29 of these 118 could the endoleaks be
treated without further surgical intervention. The conclu-
sion suggested that thoracic endografts were durable, but
long-term data are needed.31
All the patients with disease secondary to type B dissec-
tion in this study had extensive aneurysmal disease extend-
ing to include the infrarenal abdominal aorta, where flow in
the true lumen can be a problem. Performing the proce-
dure in two stages appears to have provided a solution to
this difficult problem, but these results need to be inter-
preted with caution at this early stage.
CONCLUSION
Early results of this procedure are encouraging, and we
shall continue to offer the procedure in preference to full
open repair for type I, II, and III TAAAs. This procedure
has not, so far, had the expected paraplegia risk or unac-
ceptable branch graft occlusion rates. We continue to be-
lieve that true type IV TAAAs are best treated by open
repair, but current improvement in stent-grafting may soon
allow for fenestrated stent repair of type IV as well as
juxtarenal aneurysms.
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Dr K. Craig Kent (New York, NY). You are reserving this
only for patients that you consider high risk; is that correct? And
during that same period of time, how many additional patients had
a standard thoracoabdominal repair who were not in the high-risk
category?
Mr Stephen A. Black. We did reserve this procedure in our
initial experience for high-risk patients who had no other option.
However, as we have developed it, the majority of patients have
now had the hybrid procedure performed in preference to open
repair.
Dr Richard Cambria (Boston, Mass). I have used this proce-
dure a few times in patients that I considered genuinely at risk for
an open operation, and it has, in a handful of patients, worked well.
But according to your diagram, you seem to have migrated to a
wholesale adoption of this procedure. By your data, your mortality
for this procedure is about 13%. So my question is, what were your
results with open repair that led to an apparent shift in your
paradigm to treat any patient with this procedure who appears to
be anatomically suitable?
Mr Black. This is why we have now adopted the hybrid
procedure as the preferential treatment for our patients. As we all
know, the extent of aneurysm and comorbidity are the major
factors in outcome. In a group of patients with 80% serious
comorbidity, and 50% of whom had previous aortic surgery, we
could not match these mortality rates and some would have been
refused intervention.
Dr Peter Gloviczki (Rochester, Minn). Have you used any
adjuncts like spinal fluid drainage or hypothermia or anything to
prevent paraplegia in these patients?
Mr Black. All of these patients have spinal cord drainage. We
do not use hypothermia, but the core temperature may drop to 34
degrees. We believe that one of the advantages of the stent-graft
procedure, which may account for the decrease in paraplegia rate,
is the stability of blood pressure throughout the operation and the
maintenance of aortic flow and visceral perfusion. We are looking
further into this to explain the absence of paraplegia.
Dr Piergiorgio Cao (Perugia, Italy). We have a small experi-
ence with this kind of time-consuming procedure and I’d like to
ask you a question: do you perform one-stage procedures or
double-stage procedures for these patients? I’d like to add that we
had a case of paraplegia after this procedure. In fact, the main
limitation in these cases is the impossibility to perform intercostal
revascularization.
Mr Black. To answer your first question, in the majority of
these patients we had performed a one-stage procedure. However,
in the patients with chronic dissections, we found that this initially
proved to be a problem, and we now perform the procedure in two
stages to make sure that there is adequate flow through the new
lumen to allow for the retrograde graft to be placed at a second
operation. The advantage of a one stage procedure is the ability to
deploy transabdominally where the iliac arteries are compromised
and to ensure that renal and visceral flow following stent deploy-
ment are maintained.
In answer to your second question, I completely agree. Para-
plegia is still a complication of thoracoabdominal aortic aneurysm
repair in the endovascular era, and we expect to experience this
complication.
Dr G. Melville Williams (Baltimore, Md). I stand because I
think that we are hearing something that is very, very interesting,circulation is relatively undisturbed, there is a very low incidence of
paraplegia despite the sacrifice of at least some arterial supply to the
spinal cord. Thus, we can no longer neglect the impact of visceral
ischemia, and it is up to those interested in the repair of these
extensive aneurysms to devise the best methods to minimize gut
ischemia while achieving durable repairs. The St. Mary’s group has
taken a step in this direction.
Mr Black. We certainly agree with that and we are going to be
looking into studying the physiology of these patients in more
detail.
Dr Kent. I guess I am still troubled by which patients ought to
be selected for this procedure. Again, I echo what Dr Cambria
mentioned. I wonder if Dr Wolfe would like to comment about
how he is currently approaching patients with thoracoabdominal
aneurysms.
Mr John H. N. Wolfe. Thank you very much, Craig. The
situation I think really is very much as Stephen Black has suggested.
We started off in a patient in whom we felt there was no other
choice: very extensive previous procedures (sternotomy, thoracot-
omy, laparotomy), Marfan syndrome, and young with a very large
aneurysm, and previous thoracotomies. As time has gone by, we
are now using this preferentially over open repair. We are not doing
open repair on extensive type II aneurysms. We are using this
procedure instead, because in the short term, we believe it is a great
deal safer.
Clearly, there are units and surgeons who find that they can
get excellent results with type II repairs as open procedures. But
others have a mortality rate, and a paraplegia risk that we have been
unable to overcome, despite taking all the precautions that in the
literature and which we have tried ourselves. We will do this
procedure for type II aneurysms on all patients unless there is a
reason why in that particular patient we can’t. We do not know,
obviously, the long-term results and that remains a worry, because
we do not know how durable these stent-grafts are going to be.
Dr Gloviczki. John, could you tell us if you need an infrarenal
neck of these aneurysms to suture your lower prosthesis?
Mr Wolfe. No. The hourglass procedure that Stephen pre-
sented was an obvious indication, which we performed in 1996.
But that, as you are implying, requires a long segment of normal
aorta. This series of patients had large bulbus, typical type II
thoracoabdominal aneurysms, and the stent is deployed from
proximal to the left subclavian in the majority, right all the way
through to the aortic bifurcation or beyond. Does that answer your
question?
Dr Gloviczki. In part. And then this reverse bifurcated graft is
sutured to the iliacs in that case?
Mr Wolfe. It is sutured to the iliacs below the stent-graft. Or,
if there is a previous infrarenal aneurysm repair, as you saw in our
series, we just open the aortic sac and plug it onto the previous
infrarenal aneurysm graft.
Dr Takao Ohki (Bronx, NY). In the United States, we never
had the ability to do what you did because all the stent-grafts in the
thoracics were used under a strict protocol. But now we have the
Gore TAG device, so I think we will be seeing more of these types
of procedures in the states also. I ask this question on behalf of Dr
Cambria, because you didn’t answer his question, and I really want
to know this. In the comparable group of Crawford type I, II, and
III patients that you included in your analysis, what is your
historical mortality and paraplegia rate? It is a simple question; you
must answer it.
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unable to reduce paraplegia below 7% in patients in whom the
entire thoracic and upper abdominal aorta is excluded. If less
extensive grafts are included the results are obviously better.
Dr John Chang (Roslyn, NY). I guess there is no single
answer for this complex issue. I want to ask your opinion. Some of
this is a paradigm of management. We have two patients, one with
a current ruptured thoracoabdominal aortic aneurysm and the
other with a large thoracoabdominal aortic aneurysm that devel-
oped 15 years after an abdominal aortic aneurysm repair. We
repaired these two cases by performing a bypass to the visceral
arteries and renal arteries under deep hypothermia at 18 degrees
centigrade. Then we put in an aortic graft as we warmed the patient
to minimize and prevent visceral or renal ischemia and to minimize
the risk of neurological complications. My question: Is this some-
thing that you would consider in the future to minimize visceral
ischemia and neurological complications?
Mr Black. We have used all adjuncts in the past in treating
these patients, including left heart bypass with perfusion to the
visceral segments. However, the ischemia is sufficiently limited in
this operation without resorting to deep hypothermic arrest or left
heart bypass, which is clearly advantageous. In our patients with
redo thoracotomy we have had, in the past, trouble with thoracic
cavity oozing with patients on bypass.
Dr James McKinsey (New York, NY). Two quick questions.
The first goes to other adjuncts for detection of spinal cord
ischemia. You said you are doing cerebrospinal drainage. Are you
monitoring somatosensory evoked potentials or any other neuro-
logic assessment during the time of your procedure? And the
second question pertains to the fact that three of your patients were
Marfan’s patients. And I am still very hesitant to consider endovas-
cular grafting in a Marfan’s patient. What has been your experience
both in this series and longer follow-up as well as 26 in previous
cases with Marfan’s?
Mr Black. In answer to your first question, we do not employ
other adjuncts but may need to do so if paraplegia becomes a
problem. In answer to your second question, this procedure has
demonstrated an advantage in repair of Marfan’s disease, but we do
not have long-term data. Perhaps Mr Wolfe would like to add
further to this answer.
Mr Wolfe. I think that is a very legitimate worry. I think
putting endovascular grafts into patients with Marfan’s may turn
out to be risky, and we are monitoring this very carefully both in
this group of patients and also in the patients in whom we have
been doing endografting with dissection. But the alternative in
lif
considered for surgical repair.some of these patients is very serious, and therefore, at the mo-
ment, we are prepared to take that risk.
Dr McKinsey. Just to finish—and Dr Wolfe, if you wouldn’t
mind—I think the issue that I had with the monitoring intraoper-
atively is if you are waiting for the analysis postprocedure, the
horses are out of the barn. And as you are liberalizing your
indication for doing this procedure in lower-risk patients, would
you consider changing your algorithm such that if intraoperatively
during the stent placement you start seeing significant changes in
the neurofunction and signs of spinal cord ischemia, would you
consider abandonment of the procedure and conversion into an
open procedure in a lower risk patient?
Mr Wolfe. I think if you think about what is being done in this
procedure, we spent a long time repairing the viscerals and doing
that part of the open procedure. At the end of the procedure, we
then deploy a stent. It would be at that point that the patient starts
to become paraplegic if they were going to become paraplegic. I
take your point about the evoked potentials. But I think at that
point in the procedure to then do a fully open repair, when the
patient has already been on the table for 6 hours, with our current
results, would probably be inappropriate. At the moment, I think
we are still taking that risk. And if we start to get more cases of
paraplegia, we will have to rethink.
Dr Fady Haddad (New York, NY). I have one comment. If I
understood well, there are four patients out of the 23 that are left
with an untreated proximal or type I endoleak, and these continue
to be at risk of rupture. So, were those not candidates for a
stent-graft to start with? And the second question, if those are still
at risk for rupture, and they are added to the mortality rate,
wouldn’t the mortality be comparable to an open surgical repair?
Mr Black. In answer to your question, of the four patients
who had a type I endoleak, in one patient this has resolved
following extension of the proximal arch. In the three that remain,
endoleaks have significantly reduced following extension of the
stents into the proximal arch across the crossover. We continue to
follow these patients. And I agree with you that it is a concern for
us that they have persisting endoleaks. However, in comparable
series with stenting to the aortic arch, other authors have noted
that endoleaks have persisted, and this may be due to the limita-
tions of current devices, which could possibly be overcome in the
future. In these three patients, the endoleaks are continuing to
reduce on follow-up, and the sac size has remained constant or
decreased. So possibly, the risk of rupture is still reduced in these
patients, and the risk of attempting open procedure to correct this
is still significant.INVITED COMMENTARYWilliam J. Quinones-Baldrich, MD, Los Angeles, Ca
A combined endovascular and surgical approach is emerging as a
potential alternative in the management of high-risk patients with
thoracoabdominal aneurysms. A lower incidence of paraplegia may
result from reduced visceral ischemia. Mortality, as Black et al
reported, may not be significantly different from that seen by
those centers with experience performing complete surgical
repair.
Inherent to its endovascular component, endoleaks may affect
its durability. In addition, graft-related issues such as aortoenteric
erosion or fistula may be seen with increased incidence, given the
necessary extra-anatomic routing for visceral retrograde grafts. It is
imperative to protect these grafts with either surrounding tissue or
omental flaps to avoid this long-term complication. Until longer
follow-up is available, this hybrid procedure should be reserved for
high-risk patients who would otherwise be unacceptable for stan-
dard repair. In particular, younger patients should be preferentiallyAs further refinements are made to endovascular grafts to
reduce early and long-term issues, a combined approach to repair
thoracoabdominal aneurysms is likely to gain acceptance. As re-
ported by the authors, a staged approach for patients with aortic
dissection may be preferred, assuring adequate inflow for retro-
grade grafts. Based on their experience, the hybrid procedure had
poor results in patients with ruptured aneurysms, probably related
to longer operative time. For patients with a prior thoracotomy, a
combined approach is an attractive option. Paraplegia, perhaps the
most feared complication of open repair, may be reduced.
Complete endovascular repair of complex suprarenal and tho-
racoabdominal aneurysms using branched endografts is in early
development. It may take years before this advanced technology is
available for routine use. Even then, a combined endovascular and
surgical approach may be preferred in some instances and used
with more frequency. Vascular surgeons are the principal specialists
with the necessary skills and judgment to offer all three alternatives.
